Gary Forsee - DST Systems Director
Director
Mr.Gary D. Forsee is Independent Director of the company since 2015.
Age | 66 |
Tenure | 9 years |
Phone | 816 435-1000 |
Web | www.dstsystems.com |
DST Systems Management Efficiency
The company has Return on Asset of 12.71 % which means that on every $100 spent on assets, it made $12.71 of profit. This is considered to be average in the sector. In the same way, it shows a return on shareholders' equity (ROE) of 33.39 %, implying that it generated $33.39 on every 100 dollars invested. DST Systems' management efficiency ratios could be used to measure how well DST Systems manages its routine affairs as well as how well it operates its assets and liabilities.The company has 620.8 M in debt with debt to equity (D/E) ratio of 50.0, demonstrating that the company may be unable to create cash to meet all of its financial commitments. DST Systems has a current ratio of 1.05, demonstrating that it is not liquid enough and may have problems paying out its financial commitments when the payables are due. Debt can assist DST Systems until it has trouble settling it off, either with new capital or with free cash flow. So, DST Systems' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like DST Systems sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for DST to invest in growth at high rates of return. When we think about DST Systems' use of debt, we should always consider it together with cash and equity.
Similar Executives
Showing other executives | DIRECTOR Age | ||
Louis Grabowsky | Griffon | 69 | |
Lorinda Burgess | Stepan Company | 58 | |
Ping Wong | Highway Holdings Limited | 47 | |
Richard Kerley | The Joint Corp | 67 | |
William Waldorf | Griffon | 82 | |
Kevin Sullivan | Griffon | 67 | |
Colleen Arnold | Cardinal Health | 61 | |
Randall Dearth | Stepan Company | 57 | |
Carrie Cox | Cardinal Health | 62 | |
Kuang Yang | Highway Holdings Limited | 56 | |
Joaquin Delgado | Stepan Company | 61 | |
Gregory Lawton | Stepan Company | 70 | |
Brian Geary | Highway Holdings Limited | 56 | |
Calvin Darden | Cardinal Health | 69 | |
Jillian Evanko | Parker Hannifin | 42 | |
William Fields | The Joint Corp | 65 | |
Eric Prouty | Hudson Technologies | 44 | |
Vincent Abbatecola | Hudson Technologies | 68 | |
Lacy Johnson | Griffon | 68 | |
Otto Morch | Hudson Technologies | 81 | |
James Wainscott | Parker Hannifin | 63 |
Management Performance
Return On Equity | 33.39 | |||
Return On Asset | 12.71 |
DST Systems Leadership Team
Elected by the shareholders, the DST Systems' board of directors comprises two types of representatives: DST Systems inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DST. The board's role is to monitor DST Systems' management team and ensure that shareholders' interests are well served. DST Systems' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DST Systems' outside directors are responsible for providing unbiased perspectives on the board's policies.
Steven Towle, Head of Financial Services and Executive VP | ||
Jannie Durand, Non-Executive Chairman of the Board | ||
Piet Beyers, Non-Executive Independent Director | ||
Patricia Osorio, Treasurer, Assistant Secretary | ||
Brahm Gelfand, Board Member | ||
David Lemieux, Executive Vice President | ||
Thu Do, Chief Accounting Officer | ||
Lizelle Malan, Group Company Secretary | ||
Randall Young, Sr. VP, General Counsel, Secretary and Member of Proxy Committee | ||
Charles Haldeman, Independent Director | ||
Goudreau Dubuc, Executive Officer | ||
Ethel MatengeSebesho, Non-Executive Director | ||
Chris Otto, Non-Executive Director | ||
Lucas Verwey, Group Finance Director, Executive Director | ||
Dung Bui, General Director, Member of the Board of Management | ||
Gugu Dingaan, Non-Executive Independent Director | ||
Lowell Bryan, Independent Director | ||
Jonathan Boehm, Executive VP and Head of Healthcare Bus.es | ||
Nam Truong, Member of the Board of Management | ||
Hoa Ngo, Chairman of the Board of Management | ||
Mario Jacob, Independent Director | ||
Stephen Hooley, Chairman, CEO and President and Member of Proxy Committee | ||
Joseph Antonellis, Director | ||
Donovan Hegland, Managing Director - Africa | ||
Steven Nathan, Managing Director - International | ||
Jerome Bailey, Director | ||
John Lindsay, Director | ||
Marius Lambrechts, Director - Innovations | ||
Cuong Le, Member of the Board of Management | ||
Richard Rushton, Group Managing Director, Executive Director | ||
Lynn Bleil, Director | ||
Geoff Morphy, Director | ||
Catharina SevillanoBarredo, Non-Executive Independent Director | ||
Manoochehr Abbaei, Executive Vice President Head of Customer Communications | ||
J Walt, Director - Human Resources | ||
JeanPhilippe Mai, Vice President - Business Development | ||
Luce SaintPierre, Corporate Secretary | ||
William Slattery, CEO of DSTi Holdings Limited, Chairman of IFDS Ltd. | ||
Samuel Liss, Independent Director | ||
Edmund Burke, President of ALPS Holdings, Inc. | ||
Madungandaba, Non-Executive Independent Director | ||
Brian Howlett, Interim President CEO, Director | ||
Vercie Lark, CIO and Executive VP | ||
Maria Mann, Senior Vice President CIO | ||
Elizabeth Sweetman, Chief Human Resource Officer, Senior Vice President | ||
Gregg Givens, CFO, Sr. VP, Treasurer and Member of Proxy Committee | ||
Andre Parker, Lead Independent Non-Executive Director | ||
Salvador Brouwer, Board Member | ||
JeanMarc Lalancette, Chairman Emeritus | ||
Wim Buhrmann, Managing director - Southern Africa | ||
Bridgitte Backman, Director - Corporate and Regulatory Affairs | ||
Simon HudsonLund, Executive Vice President; CEO of DST International Holdings | ||
Hubert Marleau, Director | ||
Kate Rycroft, Director - Corporate Development | ||
Schalk Klopper, Director - Supply Chain | ||
Chien Nguyen, Member of the Board of Management | ||
Mark Bowman, Non-Executive Director | ||
Mary Sweetman, Chief Human Resource Officer, Senior Vice President | ||
Arved Marin, CFO | ||
Gary Forsee, Director | ||
Prieur Plessis, Non-Executive Independent Director | ||
Dave Carruthers, Director - Global Marketing | ||
Dao Hua, Deputy Director | ||
Vatche Tchakmakian, CFO |
DST Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DST Systems a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 33.39 | |||
Return On Asset | 12.71 | |||
Profit Margin | 16.45 % | |||
Operating Margin | 13.91 % | |||
Current Valuation | 5.5 B | |||
Shares Outstanding | 60.5 M | |||
Shares Owned By Insiders | 1.05 % | |||
Shares Owned By Institutions | 88.41 % | |||
Number Of Shares Shorted | 907.89 K | |||
Price To Earning | 11.55 X |
Pair Trading with DST Systems
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DST Systems position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DST Systems will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Biogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biogen Inc to buy it.
The correlation of Biogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in DST Stock
If you are still planning to invest in DST Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the DST Systems' history and understand the potential risks before investing.
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |